Globus Medical GMED
NYSE GMED
$85.81 -2.53 (-2.87%)
At close: Aug 20, 2026 · 2:21 PM UTC

Globus Medical (GMED) Convertible Debt (2023)

Globus Medical's (GMED) quarterly Convertible Debt came in at $417.4 million in Q4 2023, up 1.87% on a QoQ basis from $409.7 million in Q3 2023.

Globus Medical (GMED) Convertible Debt (2023) Analysis & Trends

Globus Medical (GMED) has 1 years of Convertible Debt data on file, last reported at $417.4 million in Q4 2023.

  • Quarterly Convertible Debt changed N/A year-over-year to $417.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $417.4 million (changed N/A YoY) and the FY2023 annual result came in at $417.4 million, changed N/A from the prior year.
  • Convertible Debt climbed to $417.4 million in Q4 2023, from $409.7 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $417.4 million in Q4 2023 to a low of $409.7 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn
10 Globus Medical 11.59 Bn 11.00 Bn 548.17 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 417.40 Mn
Sep 30, 2023 409.72 Mn